Allogeneic Adipose-derived Mesenchymal Stem Cells: all 22 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years OldRecruitingNCT06738576Phase 1
• Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing CraniotomyRecruitingNCT05789394Phase 1
• Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot UlcersRecruitingNCT04497805Phase 2
• Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's DiseaseCompletedNCT04506073Phase 2Results posted
• Stem Cell Injection in Cancer SurvivorsCompletedNCT02509156Phase 1Results posted
• Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney DiseaseCompletedNCT05362786Phase 1
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary CompromiseWithdrawnNCT04992247Phase 2
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary CompromiseWithdrawnNCT04909892Phase 2
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress SyndromeWithdrawnNCT04909879Phase 2
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory DistressStatus unknownNCT04905836Phase 2
• Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory DistressTerminatedNCT04903327Phase 2
• Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory DistressWithdrawnNCT04728698Phase 2
• Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's SyndromeCompletedNCT04615455Phase 2
• Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.CompletedNCT04569409Phase 3
• Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot UlcersCompletedNCT03754465Phase 2
• Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.CompletedNCT03370874Phase 3
• Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot UlcersCompletedNCT02619877Phase 2
• A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury SubjectsCompletedNCT02619851Phase 2
• Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot UlcersCompletedNCT02394886Phase 1
• A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn WoundCompletedNCT02394873Phase 1
• Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver CirrhosisCompletedNCT01591200Phase 2
• A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers DiseaseCompletedNCT01484574Phase 2

← Allogeneic Adipose-derived Mesenchymal Stem Cells overview